Diaphragm resection for ovarian cancer: Technique and short-term complications

William Arthur Cliby, Sean Christopher Dowdy, Simone S. Feitoza, Bobbie S. Gostout, Karl C. Podratz

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Diaphragm resection (DR) is occasionally necessary to achieve optimal cytoreductive surgery in ovarian carcinoma (OC). In a recent survey of the SGO membership, bulky diaphragm disease was one of the most common justifications for suboptimal debulking (Gynecol. Oncol. 82 (2001) 489). The aim of this study was to assess postoperative complications of DR in OC.Retrospective chart review of all patients with OC who underwent DR from January 1988 through December 2001 at Mayo Clinic.We identified 41 women who underwent DR for OC. DR was performed during debulking for recurrent disease in 85%. Most patients (95%) underwent associated radical debulking procedures including bowel resection (51%), hepatic resection (27%), and splenectomy (17%). Full-thickness diaphragmatic lesions were present in 85% of specimens. Residual disease was classified as no gross residual in 80% of cases and <1 cm in 10%. Postoperative complications requiring treatment occurred in eight cases: pneumothorax (two cases, definitely attributable to DR); symptomatic pleural effusion (four cases, possibly attributable to DR); one case each of subphrenic abscess and gastro-pleural fistula (most likely unrelated to DR).(1) DR as part of cytoreductive surgery for ovarian cancer carries comparable risks to other radical debulking procedures. (2) The majority of complications are expected outcomes after entrance into the pleural cavity and generally manageable with chest tube. (3) DR is a useful adjunct to other radical debulking procedures and can eliminate isolated bulky diaphragmatic disease as an obstacle to optimal cytoreductive surgery for patients with ovarian cancer.

Original languageEnglish (US)
Pages (from-to)655-660
Number of pages6
JournalGynecologic Oncology
Volume94
Issue number3
DOIs
StatePublished - Sep 2004

Fingerprint

Diaphragm
Ovarian Neoplasms
Carcinoma
Subphrenic Abscess
Pleural Cavity
Chest Tubes
Pneumothorax
Splenectomy
Pleural Effusion
Fistula
Liver

Keywords

  • Cytoreduction
  • Diaphragm resection
  • Ovarian cancer
  • Surgery

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Diaphragm resection for ovarian cancer : Technique and short-term complications. / Cliby, William Arthur; Dowdy, Sean Christopher; Feitoza, Simone S.; Gostout, Bobbie S.; Podratz, Karl C.

In: Gynecologic Oncology, Vol. 94, No. 3, 09.2004, p. 655-660.

Research output: Contribution to journalArticle

Cliby, William Arthur ; Dowdy, Sean Christopher ; Feitoza, Simone S. ; Gostout, Bobbie S. ; Podratz, Karl C. / Diaphragm resection for ovarian cancer : Technique and short-term complications. In: Gynecologic Oncology. 2004 ; Vol. 94, No. 3. pp. 655-660.
@article{eacb6222d41d44cb9256407d8d1f82db,
title = "Diaphragm resection for ovarian cancer: Technique and short-term complications",
abstract = "Diaphragm resection (DR) is occasionally necessary to achieve optimal cytoreductive surgery in ovarian carcinoma (OC). In a recent survey of the SGO membership, bulky diaphragm disease was one of the most common justifications for suboptimal debulking (Gynecol. Oncol. 82 (2001) 489). The aim of this study was to assess postoperative complications of DR in OC.Retrospective chart review of all patients with OC who underwent DR from January 1988 through December 2001 at Mayo Clinic.We identified 41 women who underwent DR for OC. DR was performed during debulking for recurrent disease in 85{\%}. Most patients (95{\%}) underwent associated radical debulking procedures including bowel resection (51{\%}), hepatic resection (27{\%}), and splenectomy (17{\%}). Full-thickness diaphragmatic lesions were present in 85{\%} of specimens. Residual disease was classified as no gross residual in 80{\%} of cases and <1 cm in 10{\%}. Postoperative complications requiring treatment occurred in eight cases: pneumothorax (two cases, definitely attributable to DR); symptomatic pleural effusion (four cases, possibly attributable to DR); one case each of subphrenic abscess and gastro-pleural fistula (most likely unrelated to DR).(1) DR as part of cytoreductive surgery for ovarian cancer carries comparable risks to other radical debulking procedures. (2) The majority of complications are expected outcomes after entrance into the pleural cavity and generally manageable with chest tube. (3) DR is a useful adjunct to other radical debulking procedures and can eliminate isolated bulky diaphragmatic disease as an obstacle to optimal cytoreductive surgery for patients with ovarian cancer.",
keywords = "Cytoreduction, Diaphragm resection, Ovarian cancer, Surgery",
author = "Cliby, {William Arthur} and Dowdy, {Sean Christopher} and Feitoza, {Simone S.} and Gostout, {Bobbie S.} and Podratz, {Karl C.}",
year = "2004",
month = "9",
doi = "10.1016/j.ygyno.2004.04.032",
language = "English (US)",
volume = "94",
pages = "655--660",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Diaphragm resection for ovarian cancer

T2 - Technique and short-term complications

AU - Cliby, William Arthur

AU - Dowdy, Sean Christopher

AU - Feitoza, Simone S.

AU - Gostout, Bobbie S.

AU - Podratz, Karl C.

PY - 2004/9

Y1 - 2004/9

N2 - Diaphragm resection (DR) is occasionally necessary to achieve optimal cytoreductive surgery in ovarian carcinoma (OC). In a recent survey of the SGO membership, bulky diaphragm disease was one of the most common justifications for suboptimal debulking (Gynecol. Oncol. 82 (2001) 489). The aim of this study was to assess postoperative complications of DR in OC.Retrospective chart review of all patients with OC who underwent DR from January 1988 through December 2001 at Mayo Clinic.We identified 41 women who underwent DR for OC. DR was performed during debulking for recurrent disease in 85%. Most patients (95%) underwent associated radical debulking procedures including bowel resection (51%), hepatic resection (27%), and splenectomy (17%). Full-thickness diaphragmatic lesions were present in 85% of specimens. Residual disease was classified as no gross residual in 80% of cases and <1 cm in 10%. Postoperative complications requiring treatment occurred in eight cases: pneumothorax (two cases, definitely attributable to DR); symptomatic pleural effusion (four cases, possibly attributable to DR); one case each of subphrenic abscess and gastro-pleural fistula (most likely unrelated to DR).(1) DR as part of cytoreductive surgery for ovarian cancer carries comparable risks to other radical debulking procedures. (2) The majority of complications are expected outcomes after entrance into the pleural cavity and generally manageable with chest tube. (3) DR is a useful adjunct to other radical debulking procedures and can eliminate isolated bulky diaphragmatic disease as an obstacle to optimal cytoreductive surgery for patients with ovarian cancer.

AB - Diaphragm resection (DR) is occasionally necessary to achieve optimal cytoreductive surgery in ovarian carcinoma (OC). In a recent survey of the SGO membership, bulky diaphragm disease was one of the most common justifications for suboptimal debulking (Gynecol. Oncol. 82 (2001) 489). The aim of this study was to assess postoperative complications of DR in OC.Retrospective chart review of all patients with OC who underwent DR from January 1988 through December 2001 at Mayo Clinic.We identified 41 women who underwent DR for OC. DR was performed during debulking for recurrent disease in 85%. Most patients (95%) underwent associated radical debulking procedures including bowel resection (51%), hepatic resection (27%), and splenectomy (17%). Full-thickness diaphragmatic lesions were present in 85% of specimens. Residual disease was classified as no gross residual in 80% of cases and <1 cm in 10%. Postoperative complications requiring treatment occurred in eight cases: pneumothorax (two cases, definitely attributable to DR); symptomatic pleural effusion (four cases, possibly attributable to DR); one case each of subphrenic abscess and gastro-pleural fistula (most likely unrelated to DR).(1) DR as part of cytoreductive surgery for ovarian cancer carries comparable risks to other radical debulking procedures. (2) The majority of complications are expected outcomes after entrance into the pleural cavity and generally manageable with chest tube. (3) DR is a useful adjunct to other radical debulking procedures and can eliminate isolated bulky diaphragmatic disease as an obstacle to optimal cytoreductive surgery for patients with ovarian cancer.

KW - Cytoreduction

KW - Diaphragm resection

KW - Ovarian cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=4444365590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444365590&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2004.04.032

DO - 10.1016/j.ygyno.2004.04.032

M3 - Article

C2 - 15350355

AN - SCOPUS:4444365590

VL - 94

SP - 655

EP - 660

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -